Zai Lab Ltd — Investor Relations & Filings
Filings indexed
640
across all filing types
Latest filing
2026-05-21
Board/Management Inform…
Country
US
United States of America
Listing
US
ZLAB
Zai Lab Ltd. is a global, research-based, commercial-stage biopharmaceutical company dedicated to discovering, developing, and commercializing innovative medicines. The company focuses on advancing breakthrough therapies to address significant unmet medical needs for patients worldwide. Its strategy combines in-house discovery with strategic global partnerships to build a robust product pipeline. The primary therapeutic areas of focus include oncology, immunology, neuroscience, and infectious diseases. Zai Lab aims to leverage its competencies to positively impact human health by bringing novel treatments from the laboratory to patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-21 | English | |
| 10-Q - Zai Lab Ltd (0001704292) (Filer) | 2026-05-07 | English | |
| 8-K - Zai Lab Ltd (0001704292) (Filer) | 2026-05-07 | English | |
| ARS - Zai Lab Ltd (0001704292) (Filer) | 2026-04-28 | English | |
| DEF 14A - Zai Lab Ltd (0001704292) (Filer) | 2026-04-28 | English | |
| 10-K - ZAI LAB LTD (0001704292) (Filer) | 2026-02-26 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 46754043 | 8-K | 2026-05-21 | English | ||
| 42757486 | 10-Q - Zai Lab Ltd (0001704292) (Filer) | 2026-05-07 | English | ||
| 42764298 | 8-K - Zai Lab Ltd (0001704292) (Filer) | 2026-05-07 | English | ||
| 37970880 | ARS - Zai Lab Ltd (0001704292) (Filer) | 2026-04-28 | English | ||
| 37966968 | DEF 14A - Zai Lab Ltd (0001704292) (Filer) | 2026-04-28 | English | ||
| 32896996 | 10-K - ZAI LAB LTD (0001704292) (Filer) | 2026-02-26 | English | ||
| 32896995 | 8-K - ZAI LAB LTD (0001704292) (Filer) | 2026-02-26 | English | ||
| 31386504 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 31386516 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 31386453 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 31386433 | SCHEDULE 13G/A Filing | 2026-02-10 | English | ||
| 31386440 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 13028552 | Director's Dealing 2026 | 2026-01-02 | English | ||
|
2025
2 filings
| |||||
| 13028554 | Regulatory Filings 2025 | 2025-12-31 | English | ||
| 13028553 | Director's Dealing 2025 | 2025-12-18 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Zai Lab Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31208/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31208 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31208 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31208 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31208}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Zai Lab Ltd (id: 31208)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.